The main thrust of this laboratory is to develop experimental approaches to the study of leukemia founded on immunogenetic principles that might be helpful in achieving progress toward the control or elimination of leukemia in man. We seek to address the following specific goals. (1) Study viral sequences flanking MHC genes and their interactions with Class I genes. To do so we shall (a) clone at least one viral genome located in the TL region and prepare a single copy molecular probe and monoclonal antibodies specific for this virus; (b) sequence portions of the H-2 gene flanking the viral genome cloned, so that a synthetic oligonucleotide probe specific for this H-2 gene can be made and its expression studied and (c) examine other Class I gene regions in C57BL/10 mouse cells and all Class I gene regions in BALB/c mouse cells for flanking viral sequences. (2) Clone minor histocompatibility gene H-30 (and possibly H-34). To accomplish this goal we shall: (a) For H-30 cloning, prepare and screen a cosmid library from a Chinese hamster x mouse somatic cell line containing only murine chromsomes 2, 14, and 17 (H-30 is on chromosome 2) with a 358 bp viral probe derived from the H-30 region; (b) develop cytolytic killer cells (CTL) to assay for the H-30 gene product in transfectants generated by transformation of mouse fibroblasts with DNA derived from putative H-30 region cosmid clones, and (c) for H-34 cloning screen available cloned chromosome 12 derived segments of genomic DNA for H-34 by transfection and CTL assay. The intial experiments, will permit us to begin to address important features regarding the evolutionary implications to host and virus of the current observations and allow cloning of minor H genes for the first time.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA031346-08
Application #
3169546
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1982-07-01
Project End
1991-02-28
Budget Start
1990-03-01
Budget End
1991-02-28
Support Year
8
Fiscal Year
1990
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Pampeno, C L; Meruelo, D (1996) A novel cDNA transcript expressed in fractionated X-irradiation-induced murine thymomas. Cell Growth Differ 7:1113-23
Suzuki, H; Brown, G D; Ohno, K et al. (1996) Infection of human cells by murine ecotropic viruses: retroviral vectors carrying the hygromycin resistance-encoding gene. Gene 170:255-9
Yoshimoto, T; Yoshimoto, E; Meruelo, D (1993) Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus. J Virol 67:1310-4
Tsiagbe, V K; Yoshimoto, T; Asakawa, J et al. (1993) Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J 12:2313-20
Nobunaga, T; Brown, G D; Morris, D R et al. (1992) A novel DNA binding activity is elevated in thymocytes expressing high levels of H-2Dd after radiation leukemia virus infection. J Immunol 149:871-9
Yoshimoto, T; Yoshimoto, E; Meruelo, D (1992) Enhanced gene expression of the murine ecotropic retroviral receptor and its human homolog in proliferating cells. J Virol 66:4377-81
Kamiura, S; Nolan, C M; Meruelo, D (1992) Long-range physical map of the Ly-6 complex: mapping the Ly-6 multigene family by field-inversion and two-dimensional gel electrophoresis. Genomics 12:89-105
Yoshimoto, T; Yoshimoto, E; Meruelo, D (1991) Molecular cloning and characterization of a novel human gene homologous to the murine ecotropic retroviral receptor. Virology 185:10-7
Brown, G D; Nobunaga, T; Morris, D R et al. (1991) In vivo stimulation of H-2Dd expression following RadLV infection of thymocytes: increased transcription and DNA-binding activity to sequences 5' of the Dd gene. Res Immunol 142:431-40
Brown, G D; Egan, G; Dowling, T et al. (1990) Increased H-2Dd expression following infection by a molecularly cloned ecotropic MuLV. Immunogenetics 31:94-103

Showing the most recent 10 out of 23 publications